Cite
HARVARD Citation
Parmar, D. et al. (2020). Saroglitazar magnesium improves lipid parameters in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis. Atherosclerosis. pp. e47-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parmar, D. et al. (2020). Saroglitazar magnesium improves lipid parameters in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis. Atherosclerosis. pp. e47-. [Online].